These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9210184)

  • 41. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of dry powder aerosolization mechanisms in different channel designs.
    Chen L; Heng RL; Delele MA; Cai J; Du DZ; Opara UL
    Int J Pharm; 2013 Nov; 457(1):143-9. PubMed ID: 24055441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D; Maver U; Chan HK; Planinšek O
    J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deposition patterns with Turbuhaler.
    Borgström L
    J Aerosol Med; 1994; 7(Suppl 1):S49-53. PubMed ID: 10147081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SCF-engineered powders for delivery of budesonide from passive DPI devices.
    Lobo JM; Schiavone H; Palakodaty S; York P; Clark A; Tzannis ST
    J Pharm Sci; 2005 Oct; 94(10):2276-88. PubMed ID: 16136557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy and tolerance of terbutaline and budesonide administered via a pressurized aerosol inhaler or a Turbohaler in asthmatic patients].
    Zellweger JP; Anderhub HP; Langloh P
    Schweiz Rundsch Med Prax; 1993 May; 82(19):561-4. PubMed ID: 8506434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Okamoto H; Danjo K
    Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation.
    Pornputtapitak W; El-Gendy N; Mermis J; O'Brien-Ladner A; Berkland C
    Int J Pharm; 2014 Feb; 462(1-2):19-28. PubMed ID: 24374223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.
    Zeng XM; Martin GP; Marriott C; Pritchard J
    J Pharm Sci; 2001 Sep; 90(9):1424-34. PubMed ID: 11745794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach.
    Zhou QT; Qu L; Larson I; Stewart PJ; Morton DA
    Int J Pharm; 2010 Jul; 394(1-2):50-9. PubMed ID: 20435112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of dry powder inhalers.
    Chougule MB; Padhi BK; Jinturkar KA; Misra A
    Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, development and performance of a novel multidose dry-powder inhaler.
    Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE
    Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of electrostatic charge decay in pharmaceutical powders and polymer materials used in dry powder inhaler devices.
    Carter PA; Rowley G; Fletcher EJ; Stylianopoulos V
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1083-8. PubMed ID: 9876564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles.
    Bennett FS; Carter PA; Rowley G; Dandiker Y
    Drug Dev Ind Pharm; 1999 Jan; 25(1):99-103. PubMed ID: 10028425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
    Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
    NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.